Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancerRupert Bartsch, Guenther G. Steger, Catharina De Vries et al.|BMC Cancer|2009Cited by 22
Ventilation with the combitube during tracheotomyChristoph Wiltschke, Michael Frass, Thomas Staudinger et al.|The Laryngoscope|1994Cited by 18
Impact of Her-2-Targeted Therapy on Overall Survival in Patients With Her-2 Positive Metastatic Breast CancerAnna S. Berghoff, Rupert Bartsch, Christoph Zielinski et al.|The Breast Journal|2013Cited by 17